id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-1998-N-0051-0049,FDA,FDA-1998-N-0051,"Application for Exemption from Block Drug Company, Inc., (Hyman, Phelps, and McNamara, PC)",Other,Application,2010-03-01T05:00:00Z,2010,3,2010-03-01T05:00:00Z,,2016-08-11T19:34:50Z,,0,0,090000648056e8a9
FDA-1998-N-0051-0050,FDA,FDA-1998-N-0051,Request for Extension of Compliance (21CFR201.66) from Bayer Healthcare LLC,Other,Request for Extension,2010-03-01T05:00:00Z,2010,3,2010-03-01T05:00:00Z,,2016-08-04T15:13:39Z,,0,0,0900006480aa9a20
FDA-1998-N-0051-0051,FDA,FDA-1998-N-0051,"Attachment 1 Alka-Seltzer Plus (ASP) Products Requiring Extension of April 29, 2010 Implementation Date for the Organ Specific Warnings re: Request for Extension of Compliance (21CFR201.66) from Bayer Healthcare LLC",Supporting & Related Material,Background Material,2010-03-01T05:00:00Z,2010,3,,,2016-08-04T15:13:23Z,,0,0,0900006480aad2cb
FDA-1998-N-0051-0052,FDA,FDA-1998-N-0051,Attachment 2 Current Alka-Seltzer Plus Package Labeling re: Request for Extension of Compliance (21CFR201.66) from Bayer Healthcare LLC,Supporting & Related Material,Background Material,2010-03-01T05:00:00Z,2010,3,,,2016-08-04T15:12:57Z,,0,0,0900006480aad398